Ex Parte Trosser et alDownload PDFPatent Trial and Appeal BoardAug 21, 201310399713 (P.T.A.B. Aug. 21, 2013) Copy Citation UNITED STATES PATENT AND TRADEMARK OFFICE UNITED STATES DEPARTMENT OF COMMERCE United States Patent and Trademark Office Address: COMMISSIONER FOR PATENTS P.O. Box 1450 Alexandria, Virginia 22313-1450 www.uspto.gov APPLICATION NO. FILING DATE FIRST NAMED INVENTOR ATTORNEY DOCKET NO. CONFIRMATION NO. 10/399,713 08/25/2003 Heinrich Trosser 25421 5639 34375 7590 08/22/2013 NATH, GOLDBERG & MEYER 112 South West Street Alexandria, VA 22314 EXAMINER PALENIK, JEFFREY T ART UNIT PAPER NUMBER 1615 MAIL DATE DELIVERY MODE 08/22/2013 PAPER Please find below and/or attached an Office communication concerning this application or proceeding. The time period for reply, if any, is set in the attached communication. PTOL-90A (Rev. 04/07) UNITED STATES PATENT AND TRADEMARK OFFICE __________ BEFORE THE PATENT TRIAL AND APPEAL BOARD __________ Ex parte HEINRICH TROSSER and JULIANE BRUGGEMANN __________ Appeal 2011-013408 Application 10/399,713 Technology Center 1600 __________ Before ERIC GRIMES, ERICA A. FRANKLIN, and ANNETTE R. REIMERS, Administrative Patent Judges. FRANKLIN, Administrative Patent Judge. DECISION ON APPEAL This is an appeal under 35 U.S.C. § 134(a) involving claims to a rehydrated aqueous magaldrate composition and processes for producing a rehydrated aqueous magaldrate composition. The Patent Examiner rejected the claims as anticipated and obvious. We have jurisdiction under 35 U.S.C. § 6(b). We affirm-in-part. STATEMENT OF THE CASE “Magaldrate has been used for a long time as [an] antacid product….” (Spec. 1.) The claimed invention concerns a “process for producing Appeal 2011-013408 Application 10/399,713 2 rehydrated magaldrate preparations from magaldrate powder by mechanical treatment of aqueous suspensions of magaldrate powder.” (Id. at 2.) Claims 7-12, 15-20, 22, 23 and 26 are on appeal.1 Claims 7 and 15 are representative and read as follows: 7. A process for producing a rehydrated aqueous magaldrate composition from magaldrate powder, comprising: mixing magaldrate powder and water to form an aqueous suspension; and mechanically treating the aqueous suspension to produce the rehydrated aqueous magaldrate composition, wherein the rehydrated aqueous magaldrate composition consists of magaldrate powder, water and optionally one or more of a preservative, a flavoring, a flocculation preventing agent, a thickener, and a sweetener. 15. A rehydrated aqueous magaldrate composition, consisting of a mechanically treated mixture of magaldrate powder and water and optionally one or more of a preservative, a flavoring, a flocculation-preventing agent, a thickener, and a sweetener, wherein the composition is an aqueous suspension. (Emphasis added.) The Examiner rejected2 the claims as follows: 1 Claim 21 is also pending (App. Br. 5, Ans. 3) but is not included in any of the rejections on appeal. 2 Appellants request review of objections to (a) the Oath/Declaration as defective, subsequently withdrawn by the Examiner (Ans. 13) and (b) of claims 15, 17 and 26 under 37 C.F.R. § 1.75 as duplicate claims of each other. (App. Br. 10.) As these objections are not rejections of claims, they are not appealable matters; review should be sought by petition, not appeal. See MPEP §1201 (“The Board will not ordinarily hear a question that should be decided by the Director on petition ....”); see also MPEP § 1002.02(c)(4) (petitions relating to objections or requirements made by Examiners). Appeal 2011-013408 Application 10/399,713 3 • claims 7-11, 15-20, 22 and 26 under 35 U.S.C. §102(b) as anticipated by Wu;3 • claims 15-17 and 26 under 35 U.S.C. §102(b) as anticipated by Phadke;4 • claims 7, 8, 11, 15-17 and 26 under 35 U.S.C. §102(b) as anticipated by Brown;5 and • claims 12 and 23 under 35 U.S.C. § 103(a) as unpatentable over Brown and Bühler.6 ANTICIPATION I. Wu The Examiner found that Wu taught the claimed invention. (Ans. 7- 8.) Appellants contend that Wu does not teach the claimed processes and composition because Wu requires the inclusion of polyhydric alcohol, a first fluidizer of aluminum hydroxide gel and a second fluidizer of potassium citrate, which are “components outside of those recited in the present claims,” which limit the composition components with “consists of” and “consisting of” language. (App. Br. 13.) The Examiner responds that the claims recite “a sweetener” and that polyhydric alcohol is a sugar alcohol known in the art as a sweetener. 3US Patent No. 4,676,984 issued to Chien-Chin Wu et al., Jun. 30, 1987. 4US Patent No. 5,302,396 issued to Deepak S. Phadke et al., Apr. 12, 1994. 5US Patent No. 3,579,634 issued to Garland Richard Brown et al., May 18, 1971. 6 US Patent No. 4,304,362 issued to Gerhard Bühler, Dec. 8, 1981. Appeal 2011-013408 Application 10/399,713 4 (Ans. 14.) Additionally, the Examiner responds that the claims recite “a preservative” and that Wu’s second fluidizer of a citric acid (e.g., potassium citrate) is a natural preservative. (Id.) However, as Appellants have asserted, Wu also required the inclusion of a first fluidizer of aluminum hydroxide gel, which the Examiner has not established was within the bounds of the claim limitations. Therefore, we agree with Appellants that the Examiner has not established that Wu disclosed the claimed invention. See Verdegaal Bros. v. Union Oil Co. of California, 814 F.2d 628, 631 (Fed. Cir. 1987). Accordingly, we reverse the rejection of claims 7-11, 15-20, 22 and 26 as anticipated by Wu. II. Phadke The Examiner’s position is that Phadke’s Example 2 taught the claimed processes and composition. (Ans. 8-9.) In particular, the Examiner found Example 2 expressly discusses employing a powder form of magaldrate as evidenced by the fact that it is sifted through a 20 mesh screen prior to being admixed with other reagents. Once sifted, the magaldrate and other components are admixed with simple syrup. Simple syrup, as known in the art is a mixture of sugar dissolved into boiling distilled water in the desired ratio. The website www.thebar.com teaches a 1:1 ratio of sugar to boiling water whereas the British Pharmacopoeia teaches a 2: 1 ratio (see "Non-medicated syrup" at http://en.wildpedia.org/wiki/Syrup). A wet granulation is formed via mechanical treatment (e.g., mixing), dried and then milled. Thus, the reference is considered by the Examiner as teaching each of the instantly recited limitations. (Id.) Appeal 2011-013408 Application 10/399,713 5 Appellants contend that “Phadke et al. fail[s] to teach each and every element of the presently pending claims….” (App. Br. 15.) We agree. Specifically, we find that the Examiner has not established that Phadke’s Example 2 provided a rehydrated aqueous magaldrate composition, as required by claims 15-17 and 26, much less the further requirement of claims 15 and 16, wherein the composition is an aqueous suspension. Rather, Phadke’s Example 2 provides a dried granulation that is milled, lubricated, flavored, and then compressed into tablets. (Phadke col. 6, ll. 5- 19.) Accordingly, we reverse the rejection of claims 15-17 and 26 as anticipated by Phadke. III. Brown The Examiner found that Brown’s Example 1 taught the claimed invention. (Ans. 9.) Appellants contend only that Brown does not teach the claimed processes and composition because Brown additionally requires the inclusion of a gelation agent, which is outside of the components recited in the present claims. (App. Br. 17.) However, the claims include “a thickener” as one of their optional components. (App. Br. 24-27, Claims App’x.) As the Examiner correctly explained (Ans. 17), Brown disclosed using a gelation agent as a thickener or viscosity producing agent (see Brown col. 5, ll. 65-73; col. 6, ll. 42-63). Accordingly, we affirm the rejection of claims 7, 8, 11, 15-17 and 26 as anticipated by Brown. Appeal 2011-013408 Application 10/399,713 6 OBVIOUSNESS The Examiner’s position is that Brown taught the claimed processes of claims 12 and 23, except that Brown did not expressly teach using an annular gap bead mill to grind the aqueous suspension. (Ans. 11.) However, the Examiner found that Bühler taught this limitation. (Id.) Appellants contend that Brown does not teach or suggest the claimed processes because Brown’s method requires the inclusion of a gelation agent in its composition, which component is outside of the scope of the claims. (App. Br. 22.) Further, Appellants assert that Bühler does not cure this alleged deficiency of Brown. (Id.) As discussed, we found that Brown taught that its gelation agent is included in its composition as a thickener, which is specifically recited as an optional component in the claimed invention. Accordingly, we affirm the obviousness rejection of claims 12 and 23 over Brown and Bühler. SUMMARY We reverse the rejection of claims 7-11, 15-20, 22 and 26 under 35 U.S.C. §102(b) as anticipated by Wu; we reverse the rejection of claims 15-17 and 26 under 35 U.S.C. §102(b) as anticipated by Phadke; we affirm the rejection of claims 7, 8, 11, 15-17 and 26 under 35 U.S.C. §102(b) as anticipated by Brown; and we affirm the rejection of claims 12 and 23 under 35 U.S.C. § 103(a) as unpatentable over Brown and Bühler. Appeal 2011-013408 Application 10/399,713 7 No time period for taking any subsequent action in connection with this appeal may be extended under 37 C.F.R. § 1.136(a). AFFIRMED-IN-PART lp Copy with citationCopy as parenthetical citation